Case Report
Korean J Hematol 2009; 44(3):
Published online September 30, 2009
https://doi.org/10.5045/kjh.2009.44.3.182
© The Korean Society of Hematology
다발성 골수종과 Ankylosing Spondylitis 관계
문형일, 장형진, 김지은, 고훈영, 안소희, 민창기
가톨릭대학 의과대학 내과학교실
The Association between Multiple Myeloma and Ankylosing Spondylitis
Multiple myeloma is a malignant disease of plasma cells, whereas ankylosing spondylitis is a chronic inflammatory disease of axial joints. The relationship between the two diseases is uncertain, but chronic inflammation could trigger multiple myeloma. The authors report the cases of two ankylosing spondylitis patients with a disease duration of more than 20 years, that subsequently developed IgA kappa and IgG lambda chain myeloma, respectively, and discuss the possible pathogenetic relationship between these diseases. (Korean J Hematol 2009;44:182-187.)
Keywords Multiple myeloma, Monoclonal gammopathy of undetermined significance, Ankylosing spondylitis, Inflammation, Tumor
PDF
Standard view
Export citation
Share Article
Case Report
Korean J Hematol 2009; 44(3): 182-187
Published online September 30, 2009 https://doi.org/10.5045/kjh.2009.44.3.182
Copyright © The Korean Society of Hematology.
다발성 골수종과 Ankylosing Spondylitis 관계
문형일, 장형진, 김지은, 고훈영, 안소희, 민창기
가톨릭대학 의과대학 내과학교실
The Association between Multiple Myeloma and Ankylosing Spondylitis
Hyung Il Moon, Hyoung Jin Chang, Ji Eun Kim, Hoon Young Ko, Soe Hee Ann, Chang Ki Min
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
Abstract
Multiple myeloma is a malignant disease of plasma cells, whereas ankylosing spondylitis is a chronic inflammatory disease of axial joints. The relationship between the two diseases is uncertain, but chronic inflammation could trigger multiple myeloma. The authors report the cases of two ankylosing spondylitis patients with a disease duration of more than 20 years, that subsequently developed IgA kappa and IgG lambda chain myeloma, respectively, and discuss the possible pathogenetic relationship between these diseases. (Korean J Hematol 2009;44:182-187.)
Keywords: Multiple myeloma, Monoclonal gammopathy of undetermined significance, Ankylosing spondylitis, Inflammation, Tumor
Previous Article
Article Tools
Stats or Metrics
Share this article on
Related articles in BR
-
Recent advances in cellular immunotherapy for lymphoid malignancies
Haerim Chung, Hyunsoo Cho
Blood Res 2023; 58(4): 166-172 -
Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study
Ja Min Byun, Sung-Soo Park, Sung-Soo Yoon, Ari Ahn, Myungshin Kim, Jung Yeon Lee, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Youngil Koh, Chang-Ki Min
Blood Res 2023; 58(2): 83-90 -
Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
Fatıma Ceren Tuncel, Istemi Serin, Sacide Pehlivan, Yasemin Oyaci, Mustafa Pehlivan
Blood Res 2022; 57(4): 250-255
